The Missing Diversity in Human Genetic Studies

[1]  Jennifer G. Robinson,et al.  Multi-ancestry study of blood lipid levels identifies four loci interacting with physical activity , 2019, Nature Communications.

[2]  B. Freedman,et al.  APOL1-Associated Nephropathy: A Key Contributor to Racial Disparities in CKD. , 2018, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[3]  Mary E. Haas,et al.  Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations , 2018, Nature Genetics.

[4]  Zachary A. Szpiech,et al.  Whole‐Genome Sequencing of Pharmacogenetic Drug Response in Racially Diverse Children with Asthma , 2018, American journal of respiratory and critical care medicine.

[5]  D. Curtis.  Polygenic risk score for schizophrenia is more strongly associated with ancestry than with schizophrenia , 2018, bioRxiv.

[6]  T E Klein,et al.  Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics‐Guided Warfarin Dosing: 2017 Update , 2017, Clinical pharmacology and therapeutics.

[7]  F. Piel,et al.  Sickle Cell Disease. , 2017, The New England journal of medicine.

[8]  Christopher R. Gignoux,et al.  Human demographic history impacts genetic risk prediction across diverse populations , 2016, bioRxiv.

[9]  Daniel G. MacArthur,et al.  Human knockouts and phenotypic analysis in a cohort with a high rate of consanguinity , 2017, Nature.

[10]  M. Pepper,et al.  Cystic Fibrosis in the African Diaspora , 2017, Annals of the American Thoracic Society.

[11]  D. Rader,et al.  “Pheno”menal value for human health , 2016, Science.

[12]  S. Fullerton,et al.  Genomics is failing on diversity , 2016, Nature.

[13]  Andres Metspalu,et al.  Distribution and Medical Impact of Loss-of-Function Variants in the Finnish Founder Population , 2014, PLoS genetics.

[14]  L. Luzzatto.  The rise and fall of the antimalarial Lapdap: a lesson in pharmacogenetics , 2010, The Lancet.

[15]  C. Winkler,et al.  Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans , 2010, Science.

[16]  Scott M. Williams,et al.  The Genetic Structure and History of Africans and African Americans , 2009, Science.

[17]  P. Lavori,et al.  Transthyretin V122I in African Americans with congestive heart failure. , 2006, Journal of the American College of Cardiology.

[18]  M. Ramsay,et al.  Cystic fibrosis carrier frequencies in populations of African origin , 1999, Journal of medical genetics.